Skip to content

Marc Beer, CEO Of Aegerion Pharmaceuticals, Discusses Orphan Drug Lomitapide: Bloomberg TV

October 20, 2012

       Marc Beer, CEO of Aegerion Pharmaceuticals, discusses on Bloomberg TV, the recent FDA Advisory Committee recommendation of orphan drug Lomitapide for the treatment of Homozygous Familial Hypercholesterolemia.

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: